Aradigm Reports Resu
Aradigm Reports Results of FDA Advisory Committee Meeting on Linhaliq
January 11, 2018 16:53 ET | Aradigm Corporation
HAYWARD, Calif., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Aradigm Corporation (NASDAQ:ARDM) (the “Company”) today announces that the Antimicrobial Drugs Advisory Committee (ADAC) of the US Food and Drug...